Trials / Sponsors / RegeneRx Biopharmaceuticals, Inc.
RegeneRx Biopharmaceuticals, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction Acute Myocardial Infarction, ST Elevation Myocardial Infarction, STEMI | Phase 2 | 2019-07-01 |
| Withdrawn | A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers Myocardial Infarction, Myocardial Ischemia | Phase 1 | 2008-04-01 |
| Completed | Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers Venous Stasis Ulcers | Phase 2 | 2006-07-01 |
| Completed | Study of Thymosin Beta 4 in Patients With Pressure Ulcers Pressure Ulcers | Phase 2 | 2006-05-01 |
| Terminated | A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa Epidermolysis Bullosa | Phase 2 | 2006-02-01 |